发明申请
- 专利标题： COMPOSITION OF TUMOUR-ASSOCIATED PEPTIDES AND RELATED ANTI-CANCER VACCINE
- 专利标题（中）： 肿瘤相关肽和相关抗癌药组合物
-
申请号： US12180113申请日： 2008-07-25
-
公开(公告)号： US20090148400A1公开(公告)日： 2009-06-11
- 发明人: Harpreet Singh , Steffen Walter , Toni Weinschenk , Norbert Hilf , Oliver Schoor , Claudia Lemmel
- 申请人： Harpreet Singh , Steffen Walter , Toni Weinschenk , Norbert Hilf , Oliver Schoor , Claudia Lemmel
- 申请人地址： DE Tuebingen
- 专利权人： Immatics Biotechnologies GmhH
- 当前专利权人： Immatics Biotechnologies GmhH
- 当前专利权人地址： DE Tuebingen
- 优先权： EP07014796.2 20070727
- 主分类号： A61K39/00
- IPC分类号： A61K39/00 ; A61K38/08 ; A61K38/10 ; A61K38/16 ; A61P35/00 ; A61K38/17 ; A61K39/106 ; A61K38/19
摘要：
The present invention relates to immunotherapeutic peptides and their use in immunotherapy, in particular the immunotherapy of cancer. The present invention discloses tumour-associated T-helper cell peptide epitopes, alone or in combination with other tumour-associated peptides that serve as active pharmaceutical ingredients of vaccine compositions which stimulate anti-tumour immune responses. In particular, the composition of the peptides of the present invention can be used in vaccine compositions for eliciting anti-tumour immune responses against colorectal cancer.
公开/授权文献
信息查询
